Webinar: WFI Production with Membrane Technology

Tuesday, 25 June 2019 14.00 - 15.30 h

Course No. 17326

header-image

Speakers

Fritz Röder

Fritz Röder

Merck

Background

In Europe it has become possible to produce water for injection (WFI) using non-distillation methods since March 2017. The change in the European Pharmacopoeia allows WFI production by means of suitable methods such as reverse osmosis. However, the EU Commission has also pointed out that in order to ensure the quality of a “cold-produced” WFI, other measures have to be taken than those required previously for the mandatory distillation.

The robustness of this new process has to be demonstrated. The Q&A document prepared for this purpose by the EMA provides further assistance in some areas, but also leaves many questions unanswered. In addition, the monograph on Highly Purified Water (HPW) will be suppressed as of April 2019. Now, the most obvious question is: how will HPW - after its suppression from the European Pharmacopoeia - become Water for Injection (WFI)?

Target Group

The target group of this Webinar are specialists from pharmaceutical companies (production, qualification, quality assurance) as well as from planning and plant engineering who are entrusted with the construction, operation or maintenance of WFI producing equipment.

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

The Webinar on 25 June will address and answer the following questions:
  • What is the current regulatory status? What do Pharmaceutical
  • Associations say?
  • Which technologies are appropriate for the cold production of WFI?
  • Where do the new risks lie?
  • What are the measures to counter those risks?
  • What does happen to existing HPW systems?
  • How to set up a suitable control strategy?
  • What is the feedback from pharmaceutical “cold WFI” projects?

ECA-Member*: € 149,-
Non ECA Member*: € 199,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023